MAPT and Alzheimer disease: Dysregulation of gamma rhythms is associated with cognitive deficits in neurodegenerative diseases like AD, where reduced gamma power and coherence are linked to pathological markers, including amyloid-beta (Aβ) and tau aggregation (Stam, 2010; Uhlhaas and Singer, 2010).